trending Market Intelligence /marketintelligence/en/news-insights/trending/QO_hg5a61Ys6GXQoGXjcQQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Carl Zeiss Meditec books 13.9% YOY hike in fiscal 2019 revenue

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Carl Zeiss Meditec books 13.9% YOY hike in fiscal 2019 revenue

Carl Zeiss Meditec AG said revenue for fiscal year 2019 rose 13.9% year over year to €1.46 billion.

Revenue for the prior fiscal year was €1.28 billion.

The Jena, Germany-based medical technology company booked €1.07 billion in revenue in its ophthalmic devices strategic business unit, a 14.5% year-over-year rise from €933.2 million. The increase was mainly attributable to laser systems for vision correction, as well as devices and consumables for cataract surgery.

In the microsurgery division, revenue saw a 12.4% hike to €390.7 million from €347.6 million, with continued growth in sales of visualization systems for neurosurgeons, for the treatment of tumors and vascular diseases.

Carl Zeiss Meditec reported EBIT of €264.7 million during the fiscal year, up on an annual basis from €197.1 million. EBIT margin for fiscal 2019 was 18.1%, compared to the prior year's 15.4%.

For fiscal year 2020, the company anticipates EBIT margin to be between 17% and 19%.